RUBY — Rubius Therapeutics Share News
0.000.00%
Brief: Rubius Therapeutics Added To Russell 2000 And 3000 Indexes
Brief: Rubius Therapeutics Reports Q2 Results
Potential market opportunity for Rubius' red cell platform - analysts
U.S. RESEARCH ROUNDUP-Gemphire Therapeutics, Rollins, Viasat
Brief: Rubius Therapeutics To Acquire Manufacturing Facility In Smithfield, Rhode Island
Brief: Rubius Therapeutics Shares Open About 33 Pct Above IPO Price In Debut
NASDAQ RESUMED
NASDAQ TRADE HALT REASON NOT AVAILABLE
Brief: Rubius Prices IPO Of 10.5 Mln Common Shares At $23/Share
IFR's upcoming US IPOs, follow-ons + convertibles
IFR's upcoming US IPOs, follow-ons + convertibles
IFR's upcoming US IPOs, follow-ons + convertibles
IFR's upcoming US IPOs, follow-ons + convertibles
IFR's upcoming US IPOs, follow-ons + convertibles